Table 1.
Botswana | Zimbabwe | ||
Coverage of programmes | |||
PMTCT | >90% | 56% | |
Child ART | 89% | 30% | |
Cotrimoxazole | 60% | 30% | |
Scenarios | |||
Impacts on child mortality due to HIV | |||
Stable incidence | 14% | 19% | |
No PMTCT | 380% | 17% | |
No ART | 5% | 5% | |
No cotrimoxazole | 26% | 10% |
ART, antiretroviral therapy; PMTCT, prevention of mother-to-child transmission of HIV.